Back to search
FDAFDA · Food and drugs·Recall number D-0090-2019

ADAA Cataract Drops, (Lido 1.47%, Phenyleph 0.294% Cyclopentolate 0.147%, Tropicamide 0.0735%, Moxiflox 0.0294%, Ketorolac 0.0147%) 1x 1cc syringe, Westlab Pharmacy, Inc., Gainesville, FL 32607 --- NDC 10002-2579-05

Published October 31, 2018 · Recall initiated: August 10, 2018

Summary

FDA records drug Class II recall D-0090-2019, published October 31, 2018 and initiated August 10, 2018. Recalling firm: Westlab Pharmacy, Inc. dba Westlab Pharmacy; Status: Terminated; Reported quantity: 222 syringes; Lot: Lot: 06182018@30 Exp. 08/28/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Process Controls

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Westlab Pharmacy, Inc. dba Westlab Pharmacy
Distributor
Nationwide
Lot
Lot: 06182018@30 Exp. 08/28/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ADAA Cataract Drops, (Lido 1.47%, Phenyleph 0.294% Cyclopentolate 0.147%, Tropicamide 0.0735%, Moxiflox 0.0294%, Ketorolac 0.0147%) 1x 1cc syringe, Westlab Pharmacy, Inc., Gainesville, FL 32607 --- NDC 10002-2579-05 recalled?

Yes. FDA published recall D-0090-2019 on October 31, 2018. Reported hazard: Lack of Process Controls

What should I do if I have this product?

Voluntary: Firm initiated · Letter